Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines.
Deciphera Pharmaceuticals, a member of ONO Pharma
Deciphera Pharmaceuticals, LLC
200 Smith Street
Waltham, MA 02453